Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory Signatures in MDS: The Missing Link Between Genetics, Microenvironment, and Therapy.

Cells·2026
Same author

Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.

British journal of haematology·2026
Same author

The Shape-Shifting Myeloma: Adaptive Plasticity as a Hallmark of Relapse and Refractoriness.

Cancers·2026
Same author

Proteome and miRNAs Expression in Medication-Related Osteonecrosis of the Jaw.

International journal of molecular sciences·2026
Same author

ElucidatiNg Immunosuppressant pharmacokinetic variabilities by investigating Gut Microbiome modulations After kidney transplantation (ENIGMA): study protocol of a prospective longitudinal trial.

BMJ open·2026
Same author

Microenvironmental Drivers of Bone Disease in Multiple Myeloma: Oxidative Stress, Sterile Inflammation, Autophagy-Lysosomal Remodeling, and the Iron-Lipid Peroxidation Axis.

Biomolecules·2026

Related Experiment Videos

Renal complications in oncohematologic patients.

Michele Buemi1, Maria Rosaria Fazio, Davide Bolignano

  • 1Department of Internal Medicine, University of Messina, Messina, Italy. buemim@unime.it

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|December 3, 2009
PubMed
Summary

This review covers kidney complications in cancer patients, including acute kidney injury and chronic kidney disease from cancer or its treatments. Early diagnosis and prompt therapy are crucial for managing these renal issues.

Related Experiment Videos

Area of Science:

  • Nephrology
  • Oncology
  • Hematology

Background:

  • Cancer patients frequently develop kidney complications.
  • These renal issues can arise from the cancer itself or its treatments.
  • Understanding these complications is vital for patient outcomes.

Purpose of the Study:

  • To review recent advancements in managing kidney disease in cancer patients.
  • To focus on specific renal complications associated with oncohematologic diseases and therapies.
  • To highlight the importance of early diagnosis and timely intervention.

Main Methods:

  • Literature review of recent developments.
  • Focus on specific renal pathologies: parenchymal infiltration, myeloma, tumor lysis syndrome, glomerular disease, thrombotic microangiopathy (including chemotherapy-associated), biphosphonate-induced nephropathy, and kidney disease post-hematopoietic cell transplantation.

Main Results:

  • The review synthesizes current knowledge on diverse renal complications in cancer patients.
  • Identified key areas include direct tumor effects, treatment side effects, and post-transplant kidney issues.
  • Management strategies for these conditions are discussed.

Conclusions:

  • Improved understanding of renal complications in oncohematologic diseases is essential.
  • Early diagnosis and prompt therapeutic interventions can significantly improve patient prognosis.
  • Further research is needed to refine management protocols.